Siga Technologies (SIGA) Retained Earnings (2010 - 2025)
Siga Technologies' (SIGA) quarterly Retained Earnings came in at -$43.1 million in Q4 2025, down 88.59% on a YoY basis from -$377.6 million in Q4 2024, and down 14.43% quarter-over-quarter from -$37.6 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Retained Earnings (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Retained Earnings for 16 consecutive years, with -$43.1 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 88.59% year-over-year to -$43.1 million; the trailing twelve-month figure through Dec 2025 stood at -$43.1 million (down 88.59% YoY), and the FY2025 full-year result was -$43.1 million, down 88.59% from the prior year.
- Retained Earnings retreated to -$43.1 million in Q4 2025 per SIGA's latest filing, from -$37.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$22.8 million in Q4 2024 and bottomed at -$119.2 million in Q3 2021.
- Historically, Retained Earnings has averaged -$68.0 million across 5 years, with a median of -$66.2 million in 2022.
- The widest YoY moves for Retained Earnings: up 67.62% in 2025, down 88.59% in 2025.
- Over 5 years, Retained Earnings stood at -$51.8 million in 2021, then fell by 23.26% to -$63.8 million in 2022, then surged by 38.96% to -$38.9 million in 2023, then jumped by 41.36% to -$22.8 million in 2024, then tumbled by 88.59% to -$43.1 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$43.1 million, -$37.6 million, and -$31.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -4.00 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | -43.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -43.07 Mn |
| Sep 30, 2025 | -37.64 Mn |
| Jun 30, 2025 | -31.28 Mn |
| Mar 31, 2025 | -23.25 Mn |
| Dec 31, 2024 | -22.84 Mn |
| Sep 30, 2024 | -68.60 Mn |
| Jun 30, 2024 | -69.95 Mn |
| Mar 31, 2024 | -71.78 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Sep 30, 2023 | -111.20 Mn |
| Jun 30, 2023 | -110.81 Mn |
| Mar 31, 2023 | -72.28 Mn |
| Dec 31, 2022 | -63.80 Mn |
| Sep 30, 2022 | -60.14 Mn |
| Jun 30, 2022 | -93.18 Mn |
| Mar 31, 2022 | -58.70 Mn |
| Dec 31, 2021 | -51.76 Mn |
| Sep 30, 2021 | -119.21 Mn |
| Jun 30, 2021 | -108.97 Mn |
| Mar 31, 2021 | -102.53 Mn |